Research Articles
Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.
Article Title | Original Publication Date | Journal | Bone Marrow Disease |
---|---|---|---|
To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia | Jun 2020 | Haematologica | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
PNH Phenotypes and Their Genesis | Jun 2020 | British Journal of Haematology | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes | Jun 2020 | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? | Jun 2020 | Best practice & research. Clinical haematology | Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis | Jun 2020 | Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation | Myelodysplastic Syndromes (MDS) |
Immunomodulation With Pomalidomide at Early Lymphocyte Recovery After Induction Chemotherapy in Newly Diagnosed AML and High-Risk MDS | Jun 2020 | Leukemia | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? | Jun 2020 | Best practice & research. Clinical haematology | Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
Controversies on the Consequences of Iron Overload and Chelation in MDS | May 2020 | HemaSphere | Myelodysplastic Syndromes (MDS) |
How I Diagnose Low-Grade Myelodysplastic Syndromes | May 2020 | American Journal of clinical Pathology | Myelodysplastic Syndromes (MDS) |
Myelodysplastic Syndromes: Moving Towards Personalized Management | May 2020 | Haematologica | Myelodysplastic Syndromes (MDS) |